StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.87+0.03 (+3.69%)

Close on Nov 18, 2026Market cap $13.87MP/E –Yield –

Allarity Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $320.00K.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$320.00K–
FY2024Dec 31, 2024$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$25.00K–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0–

More Allarity Therapeutics figures

See a number that looks wrong?